The page lists 20 projects related to the topic "hpv".
| # | |||
|---|---|---|---|
| 1 | PoC-Cycle | Innovative Molecular Diagnostics point-of-care device for MRSA | 2014 |
| 2 | CANCER-TECH | Cervical cancer detection platform based on novel laser processing | 2016 |
| 3 | ARC-HPV | Automated Raman spectral Cytology for detection of human papillomavirus (HPV) infection and cervical pre-cancer | 2016 |
| 4 | SixthSense | Early diagnosis of cervical cancer through the validation of Human Papilloma Virus viral load and expression of oncogenic viral proteins E6/E7 as risk indicators | 2015 |
| 5 | iTampon | Intimate, home-diagnostic tools for women | 2015 |
| 6 | EVOLPROOF | Are HPV vaccines ‘evolution-proof’? Multilevel evolutionary ecology of human oncoviruses | 2015 |
| 7 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 8 | VALPAS | VALidation of human PApilloma virus assays on Self-collected first void urine samples | 2015 |
| 9 | BD2Decide | Big Data and models for personalized Head and Neck Cancer Decision support | 2016 |
| 10 | MitoVin | Mechanism and Consequences of the Interplay between Mitosis and Human Papillomavirus Initial Infection | 2016 |
| 11 | KIRANDIS | NK receptors and disease | 2016 |
| 12 | HoloCyt | A rapid, low-cost, cervical cancer screening platform | 2017 |
| 13 | I-CONSENT | Improving the guidelines for Informed Consent, including vulnerable populations, under a gender perspective | 2017 |
| 14 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 15 | METHYVIREVOL | Virocellular hybrids and epigenomic changes as driving factors of infection driven cancers. | 2019 |
| 16 | HPV OncoPredict | A Groundbreaking Stand-Alone Diagnostic Kit to Predict Human Papilloma Virus Infections Evolving into Cervical Cancer | 2018 |
| 17 | MEsHH | DNA MEthylation for HPV-related disease among women living with HIV | 2018 |
| 18 | ELEVATE | Early detection of cervical cancer in hard-to-reach populations of women through portable and point-of-care HPV testing | 2019 |
| 19 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 20 | RISCC | RISK-BASED SCREENING FOR CERVICAL CANCER | 2020 |